UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib

Breast (Edinburgh), 2023-04, Vol.68, p.S20-S21

2023

Link zum Volltext

Verfügbarkeit prüfen

Short intensive exercise increases the migratory activity of mesenchymal stem cells

British journal of sports medicine, 2009-03, Vol.43 (3), p.195-198

2009

Link zum Volltext

Verfügbarkeit prüfen

Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking

The European respiratory journal, 2007-01, Vol.29 (1), p.42-50

2007

Link zum Volltext

Verfügbarkeit prüfen

Improved QTcF diagnostic using tele-cardiology

European journal of cancer (1990), 2020-10, Vol.138, p.S67-S67

2020

Link zum Volltext

Verfügbarkeit prüfen

Prospective, Multi-Center, Artificial Intelligence Study for Early Prediction of Serious Events under Treatment Is Now Open for Recruitment in Breast Cancer - OMCAT Trial in Progress

European journal of cancer (1990), 2022-11, Vol.175, p.S71-S72

2022

Link zum Volltext

Verfügbarkeit prüfen

Trained Artificial Intelligence (AI) for Predicting Therapy Discontinuation Based on Patient Observations in Advanced Breast Cancer

European journal of cancer (1990), 2022-11, Vol.175, p.S72

2022

Link zum Volltext

Verfügbarkeit prüfen

Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma

Cancer research (Chicago, Ill.), 2001-12, Vol.61 (24), p.8737-8742

2001

Link zum Volltext

Verfügbarkeit prüfen

AI-based smartphone App using a single-lead ECG for automated QTc diagnostics in oncology

European journal of cancer (1990), 2022-11, Vol.175, p.S71

2022

Link zum Volltext

Verfügbarkeit prüfen

Ki-4(scFv)-ETA', a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated hodgkin tumors in SCID mice

Blood, 2000-06, Vol.95 (12), p.3909-3914

2000

Link zum Volltext

Verfügbarkeit prüfen

The CINDERELLA APProach: Future Concepts for Patient Empowerment in Breast Cancer Treatment with Artificial Intelligence-Driven Healthcare Platform

European journal of cancer (1990), 2024-03, Vol.200, Article 113784

2024

Link zum Volltext

Verfügbarkeit prüfen

A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia

Leukemia, 2000-04, Vol.14 (4), p.754-766

2000

Link zum Volltext

Verfügbarkeit prüfen

75P Interim analysis (n=150) of the multi-national, prospective, non-interventional ELEANOR study observing real-life extended adjuvant treatment with neratinib in patients with HER2+ / HR+ early breast cancer (eBC)

Annals of oncology, 2022-05, Vol.33, p.S157-S157

2022

Link zum Volltext

Verfügbarkeit prüfen

Olaparib in German routine clinical practice: Updated interim results of the non-interventional study c-patrol

Gynecologic oncology, 2018-06, Vol.149, p.120-120

2018

Link zum Volltext

Verfügbarkeit prüfen

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

Annals of oncology, 2023-08, Vol.34 (8), p.660-669

2023

Link zum Volltext

Verfügbarkeit prüfen

Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia

Annals of hematology, 2002-05, Vol.81 (5), p.258-266

2002

Link zum Volltext

Verfügbarkeit prüfen

PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy

Annals of oncology, 2019-10, Vol.30, p.v142

2019

Link zum Volltext

Verfügbarkeit prüfen

389TiP - PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy

Annals of oncology, 2019-10, Vol.30, p.v142-v142

2019

Link zum Volltext

Verfügbarkeit prüfen

The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis

Clinical and experimental immunology, 2003-11, Vol.134 (2), p.253-263

2003

Link zum Volltext

Verfügbarkeit prüfen

Recombinant anti‐CD25 immunotoxin RFT5(SCFV)‐ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID mice

International journal of cancer, 2000-06, Vol.86 (5), p.718-724

2000

Link zum Volltext

Verfügbarkeit prüfen

195P Impact of an interactive eHealth system for patient reported outcomes on safety in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy

ESMO open, 2023-05, Vol.8 (1), p.101384, Article 101384

2023

Link zum Volltext

Verfügbarkeit prüfen

108TiP CINDERELLA clinical trial: Using artificial intelligence-driven healthcare to enhance breast cancer locoregional treatment decisions

ESMO open, 2024-05, Vol.9

2024

Link zum Volltext

Verfügbarkeit prüfen

The bi‐specific CD3 × NCAM antibody: a model to preactivate T cells prior to tumour cell lysis

Clinical and experimental immunology, 2003-11, Vol.134 (2), p.253-263

2003

Link zum Volltext

Verfügbarkeit prüfen

Olaparib in German routine clinical practice – Updated interim results of the non-interventional study C-PATROL

Geburtshilfe und Frauenheilkunde, 2018, Vol.78 (10)

2018

Link zum Volltext

Verfügbarkeit prüfen

Zeitreduktion um 99 % für die QTc Zeit Diagnostik durch Telekardiologie

Geburtshilfe und Frauenheilkunde, 2020, Vol.80 (6)

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(116)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(120)
Deutsch
(12)
Japanisch
(4)
Croatian
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib

Short intensive exercise increases the migratory activity of mesenchymal stem cells

Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking

Improved QTcF diagnostic using tele-cardiology

Prospective, Multi-Center, Artificial Intelligence Study for Early Prediction of Serious Events under Treatment Is Now Open for Recruitment in Breast Cancer - OMCAT Trial in Progress

Trained Artificial Intelligence (AI) for Predicting Therapy Discontinuation Based on Patient Observations in Advanced Breast Cancer

Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma

AI-based smartphone App using a single-lead ECG for automated QTc diagnostics in oncology

Ki-4(scFv)-ETA', a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated hodgkin tumors in SCID mice

The CINDERELLA APProach: Future Concepts for Patient Empowerment in Breast Cancer Treatment with Artificial Intelligence-Driven Healthcare Platform

A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia

75P Interim analysis (n=150) of the multi-national, prospective, non-interventional ELEANOR study observing real-life extended adjuvant treatment with neratinib in patients with HER2+ / HR+ early breast cancer (eBC)

Olaparib in German routine clinical practice: Updated interim results of the non-interventional study c-patrol

200TiP ELEANOR: A multi-national, prospective, non-interventional study (NIS) in patients with human epidermal growth factor receptor (HER2) positive, early breast cancer (eBC) observing real-life extended adjuvant treatment with neratinib and concurrent use of the eHealth solution CANKADO

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia

PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy

389TiP - PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy

The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis

Recombinant anti‐CD25 immunotoxin RFT5(SCFV)‐ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID mice

195P Impact of an interactive eHealth system for patient reported outcomes on safety in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy

108TiP CINDERELLA clinical trial: Using artificial intelligence-driven healthcare to enhance breast cancer locoregional treatment decisions

The bi‐specific CD3 × NCAM antibody: a model to preactivate T cells prior to tumour cell lysis

Olaparib in German routine clinical practice – Updated interim results of the non-interventional study C-PATROL

Zeitreduktion um 99 % für die QTc Zeit Diagnostik durch Telekardiologie

Suchergebnisse filtern